It was a great Q3 for mergers and acquisitions (M&A) that were on hold amid the peak of coronavirus-led lockdowns. A flurry of deals in September led to a record Q3 with more than $1 trillion worth transactions globally, according to Refinitiv data, as quoted on Reuters.
M&A activity skyrocketed 80% sequentially in Q3. These include the announcements of Nvidia-Arm deal for $40 billion, the Microsoft-ZeniMax Media deal for $7.5 billion, the Gilead Sciences–Immunomedics deal for about $21 billion, the Verizon Communications-America Movil deal for about $6.9 billion and ByteDance’s selection of Oracle as its technology partner in the United States.
While the sky-high valuation of stocks may slow down the deal-making momentum in Q4, rock-bottom interest rate levels should keep favoring the space. IQ Merger Arbitrage ETF (MNA - Free Report) has amassed about $714.8 million in assets so far. The underlying IQ Merger Arbitrage Index seeks to identify opportunities in companies involved in announced mergers, acquisitions and other buyout-related transactions. MNA has gained about 7.4% in the past three months.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
It was a great Q3 for mergers and acquisitions (M&A) that were on hold amid the peak of coronavirus-led lockdowns. A flurry of deals in September led to a record Q3 with more than $1 trillion worth transactions globally, according to Refinitiv data, as quoted on Reuters.
M&A activity skyrocketed 80% sequentially in Q3. These include the announcements of Nvidia-Arm deal for $40 billion, the Microsoft-ZeniMax Media deal for $7.5 billion, the Gilead Sciences–Immunomedics deal for about $21 billion, the Verizon Communications-America Movil deal for about $6.9 billion and ByteDance’s selection of Oracle as its technology partner in the United States.
While the sky-high valuation of stocks may slow down the deal-making momentum in Q4, rock-bottom interest rate levels should keep favoring the space. IQ Merger Arbitrage ETF (MNA - Free Report) has amassed about $714.8 million in assets so far. The underlying IQ Merger Arbitrage Index seeks to identify opportunities in companies involved in announced mergers, acquisitions and other buyout-related transactions. MNA has gained about 7.4% in the past three months.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on MNA - FREE